Pathway Progress – Biosimilars Are Coming Soon

In 2013, “biosimilars” were a hot topic at the Arizona Legislature. In the end, the bill to define the classes of biosimilars in Arizona statute  along with the the process for substitution did not move forward to the floor as key stateholders and legislators continued to research and discuss the issue.

It is expected that the first biosimilars will be approved by the FDA in 2015 and that the states that have yet to up date their pharmacy acts (including Arizona) will be opening up these discussions again.Continue reading

Biodesign Celebrates Ten Years and Launches NexTen

A decade ago, a young, vibrant research university, in partnership with people from the nation’s sixth largest metropolitan area, in the youngest state in the contiguous U.S., embarked on an ambitious initiative to launch a bioscience endeavor unlike any known before: The Biodesign Institute. By using the foundational blueprints of Nature’s grand designs, our talented researchers have pushed the frontiers of knowledge and advanced research and discovery to make a major impact on our community, nation and the world.

Continue reading